Seung-Hun Oh Selected Research

triflusal

9/2017	Effects of Triflusal and Clopidogrel on the Secondary Prevention of Stroke Based on Cytochrome P450 2C19 Genotyping.
1/2016	Protocol for the comparison of triflusal and clopidogrel in secondary prevention of stroke based on cytochrome P450 2C19 genotyping (MASETRO study): A multicenter, randomized, open-label, parallel-group trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seung-Hun Oh Research Topics

Disease

28	Stroke (Strokes) 11/2021 - 08/2012
16	Ischemic Stroke 02/2021 - 09/2011
6	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 09/2020 - 01/2013
4	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 11/2021 - 01/2013
3	Cerebral Infarction 11/2021 - 03/2013
3	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2017
3	Neuroinflammatory Diseases 09/2020 - 01/2018
3	Brain Ischemia (Cerebral Ischemia) 04/2016 - 04/2013
3	Inflammation (Inflammations) 04/2016 - 01/2014
3	Infarction (Infarctions) 08/2015 - 01/2003
2	Atherosclerosis 11/2021 - 01/2017
2	Vascular Diseases (Vascular Disease) 02/2021 - 01/2013
2	Gliosis 09/2020 - 11/2013
2	Hypertension (High Blood Pressure) 05/2019 - 01/2011
2	Aneurysm (Aneurysms) 05/2019 - 06/2009
2	Intracranial Aneurysm (Cerebral Aneurysm) 05/2019 - 06/2009
2	Lung Neoplasms (Lung Cancer) 01/2019 - 01/2018
2	Neoplasms (Cancer) 01/2019 - 01/2018
2	Cerebral Small Vessel Diseases 01/2017 - 01/2015
2	Ischemia 08/2015 - 01/2013
2	Moyamoya Disease (Moya-Moya Disease) 10/2014 - 01/2012
1	Spinal Cord Injuries (Spinal Cord Injury) 06/2021
1	Contusions 06/2021
1	Hyperalgesia 06/2021
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 10/2020
1	Hyperlipidemias (Hyperlipidemia) 01/2020
1	Dyslipidemias (Dyslipidemia) 01/2020
1	Rupture 05/2019
1	Diabetes Mellitus 05/2019
1	Cerebral Hemorrhage 05/2019
1	Cognitive Dysfunction 01/2019
1	Drug Resistant Epilepsy 06/2018
1	Status Epilepticus (Complex Partial Status Epilepticus) 06/2018
1	Carcinogenesis 01/2018
1	Prodromal Symptoms 01/2017
1	Vascular System Injuries 01/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2016
1	Atrial Fibrillation 03/2015
1	Transient Ischemic Attack 03/2015
1	Vascular Calcification 01/2015

Drug/Important Bio-Agent (IBA)

8	Therapeutic UsesIBA 06/2021 - 01/2013
5	Proteins (Proteins, Gene)FDA Link 05/2019 - 06/2004
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 06/2013
4	Interleukin-6 (Interleukin 6)IBA 09/2014 - 06/2009
3	Mannitol (Osmitrol)FDA LinkGeneric 10/2020 - 01/2018
3	MicroRNAs (MicroRNA)IBA 05/2019 - 01/2018
3	Messenger RNA (mRNA)IBA 05/2019 - 08/2012
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2014 - 08/2012
3	HomocysteineIBA 07/2013 - 01/2011
2	ResistinIBA 11/2021 - 09/2014
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 06/2021 - 01/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 08/2002
2	Neuroprotective AgentsIBA 01/2019 - 08/2015
2	Anticonvulsants (Antiepileptic Drugs)IBA 06/2018 - 06/2007
2	Cytochrome P-450 CYP2C19IBA 09/2017 - 01/2016
2	triflusalIBA 09/2017 - 01/2016
2	Clopidogrel (Plavix)FDA Link 09/2017 - 01/2016
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 09/2017 - 01/2016
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 09/2017 - 01/2016
2	Glial Fibrillary Acidic ProteinIBA 11/2013 - 03/2013
2	Fatty Acid-Binding ProteinsIBA 04/2013 - 03/2013
2	Phosphopyruvate Hydratase (Enolase)IBA 03/2013 - 01/2003
2	Phosphotransferases (Kinase)IBA 01/2012 - 09/2011
1	Testosterone (Sustanon)FDA Link 02/2021
1	Estradiol (Delestrogen)FDA LinkGeneric 02/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 02/2021
1	Neprilysin (Neutral Endopeptidase)IBA 01/2021
1	LigandsIBA 10/2020
1	ChemokinesIBA 10/2020
1	HDL CholesterolIBA 01/2020
1	HDL-triglycerideIBA 01/2020
1	CholesterolIBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2019
1	Adalimumab (Humira)FDA Link 01/2019
1	LuciferasesIBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2018
1	Evans Blue (Blue, Evans)FDA Link 01/2018
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2018
1	Temozolomide (Temodar)FDA LinkGeneric 01/2018
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2018
1	Tight Junction ProteinsIBA 01/2018
1	OccludinIBA 01/2018
1	Drug CombinationsIBA 01/2018
1	Coloring Agents (Dyes)IBA 01/2018
1	Amyloid (Amyloid Fibrils)IBA 01/2017
1	BilirubinIBA 01/2017
1	PrionsIBA 10/2016
1	salicylhydroxamic acid (SHAM)IBA 04/2016
1	Warfarin (Coumadin)FDA LinkGeneric 03/2015
1	Alkaline PhosphataseIBA 01/2015
1	Tissue Inhibitor of MetalloproteinasesIBA 10/2014
1	Tissue Inhibitor of Metalloproteinase-2IBA 10/2014

Therapy/Procedure

8	Transplantation 06/2021 - 05/2012
8	Therapeutics 01/2020 - 03/2015
3	Intravenous Administration 10/2020 - 04/2016
2	Secondary Prevention 09/2017 - 01/2016
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2013 - 11/2012
1	Catheters 06/2021
1	Injections 01/2020